Monitoring potential prostate cancer biomarkers in urine by capillary electrophoresis–tandem mass spectrometry
Authors:
- Yu HuiYHYu Hui
- Amitha K. HewavitharanaAHAmitha K. Hewavitharana
- David D.Y. ChenDCDavid D.Y. Chen
- 1 December 2012
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 1267, 162-169
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Reproducible and High-Throughput HPLC/MS Method To Separate Sarcosine from α- and β-Alanine and To Quantify Sarcosine in Human Serum and UrineAnalytical Chemistry, 2011
- Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical ProgressionJournal of Urology, 2011
- International Guidelines for Bioanalytical Method Validation: A Comparison and Discussion on Current ScenarioChromatographia, 2011
- Quantitative Determination of Sarcosine and Related Compounds in Urinary Samples by Liquid Chromatography with Tandem Mass SpectrometryAnalytical Chemistry, 2010
- Markers for Detection of Prostate CancerCancers, 2010
- Urine markers in monitoring for prostate cancerProstate Cancer and Prostatic Diseases, 2009
- Differential 12C-/13C-Isotope Dansylation Labeling and Fast Liquid Chromatography/Mass Spectrometry for Absolute and Relative Quantification of the MetabolomeAnalytical Chemistry, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- HMDB: the Human Metabolome DatabaseNucleic Acids Research, 2007